alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
REPORT OF INDEPENDENT
AUDITORS


The Board of Directors
Nuveen Exchange-Traded Funds

In planning and performing our audit of the financial statements
of each of the Nuveen Exchange-Traded Funds listed in Exhibit
A attached hereto (the Funds) for the year ended June 30,
2000, we considered its internal control, including control
activities for safeguarding securities, to determine our auditing
procedures for the purpose of expressing our opinion on the
financial statements and to comply with the requirements of
Form N-SAR, and not to provide assurance on internal control.

The management of the Funds is responsible for establishing
and maintaining internal control.  In fulfilling this responsibility,
estimates and judgments by management are required to assess
the expected benefits and related costs of internal control.
Generally, internal controls that are relevant to an audit pertain
to the entitys objective of preparing financial statements for
external purposes that are fairly presented in conformity with
generally accepted accounting principles.  Those internal
controls include the safeguarding of assets against unauthorized
acquisition, use, or disposition.

Because of inherent limitations in any internal control,
misstatements due to errors or fraud may occur and not be
detected.  Also, projections of any evaluation of internal control
to future periods are subject to the risk that internal control may
become inadequate because of changes in conditions, or that the
degree of compliance with the policies or procedures may
deteriorate.

Our consideration of internal control would not necessarily
disclose all matters in internal control that might be material
weaknesses under standards established by the American
Institute of Certified Public Accountants. A material weakness is
a condition in which the design or operation of one or more of
the specific internal control components does not reduce to a
relatively low level the risk that errors or fraud in amounts that
would be material in relation to the financial statements being
audited may occur and not be detected within a timely period by
employees in the normal course of performing their assigned
functions.  However, we noted no matters involving internal
control, including control activities for safeguarding securities,
and its operation that we consider to be material weaknesses as
defined above as of June 30, 2000.

This report is intended solely for the information and use of the
Board of Directors and management of the Nuveen Exchange-
Traded Funds and the Securities and Exchange Commission and
is not intended to be and should not be used by anyone other
than these specified parties.



/s/ ERNST & YOUNG LLP

Chicago, Illinois
August 18, 2000

Exhibit A



Nuveen Florida Investment Quality Municipal Fund, Inc.
Nuveen Florida Quality Income Municipal Fund, Inc.
Nuveen Insured Florida Premium Income Municipal Fund,
Inc.
Nuveen New Jersey Investment Quality Municipal Fund,
Inc.
Nuveen New Jersey Premium Income Municipal Fund, Inc.
Nuveen Pennsylvania Investment Quality Municipal Fund,
Inc.
Nuveen Pennsylvania Premium Income Municipal Fund 2,
Inc.
I 

115TH CONGRESS 

1ST SESSION H. R. 544 

To amend title 18, United States Code, to provide for penalties for the 

sale of any Purple Heart awarded to a member of the Armed Forces. 

IN THE HOUSE OF REPRESENTATIVES 

JANUARY 13, 2017 

Mr. COOK (for himself, Mr. BISHOP of Georgia, Ms. JUDY CHU of California, 

Ms. JENKINS of Kansas, Mr. POLIQUIN, and Mr. DUNN) introduced the 

following bill; which was referred to the Committee on the Judiciary 

A BILL 

To amend title 18, United States Code, to provide for penalties for the sale of any Purple Heart awarded to a 

member of the Armed Forces. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Private Corrado Piccoli 

5 Purple Heart Preservation Act’’. 

6 SEC. 2. FINDINGS. 

7 Congress finds the following: 

8 (1) The Purple Heart medal solemnly recog9 nizes the great and sometimes ultimate sacrifice of 


SSpencer on DSK4SPTVN1PROD with BILLS
2 

•HR 544 IH

1 American servicemembers like Private Corrado 

2 Piccoli. 

3 (2) The Purple Heart medal holds a place of 

4 honor as the national symbol of this sacrifice and 

5 deserves special protections. 

6 SEC. 3. PENALTY FOR SALE OF PURPLE HEARTS AWARDED 

7 TO MEMBERS OF THE ARMED FORCES. 

8 Subsection (a) of section 704 of title 18, United 

9 States Code, is amended to read as follows: 

10 ‘‘(a) IN GENERAL.— 

11 ‘‘(1) PENALTY.—Whoever knowingly purchases, 

12 attempts to purchase, solicits for purchase, mails, 

13 ships, imports, exports, produces blank certificates 

14 of receipt for, manufactures, sells, attempts to sell, 

15 advertises for sale, trades, barters, or exchanges for 

16 anything of value any decoration or medal author17 ized by Congress for the armed forces of the United 

18 States, or any of the service medals or badges 

19 awarded to the members of such forces, or the rib20 bon, button, or rosette of any such badge, decoration 

21 or medal, or any colorable imitation thereof, except 

22 when authorized under regulations made pursuant to 

23 law, shall be fined under this title or imprisoned not 

24 more than six months, or both. 


SSpencer on DSK4SPTVN1PROD with BILLS
3 

•HR 544 IH

1 ‘‘(2) LIMITATION ON REGULATIONS.—Regula2 tions referred to in paragraph (1) may not authorize 

3 the sale of any Purple Heart awarded to a member 

4 of the armed forces or former member of the armed 

5 forces by the Secretary of the military department 

6 concerned.’’. 

Æ 


SSpencer on DSK4SPTVN1PROD with BILLS
**EXHIBIT 31.2**

 

**CHIEF FINANCIAL OFFICER CERTIFICATION UNDER SECTION 302 OF THE**

**SARBANES-OXLEY ACT**

 

I, James D. Constantine, Executive Vice President and Chief Financial and Administrative Officer of Factory Card & Party Outlet Corp., certify that: 

 

1.  I have reviewed this annual report Form 10-K of Factory Card & Party Outlet Corp; 

 

2.  Based on my knowledge, this report does not contain any untruestatement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the periods covered by this annual report;

 

3.  Based on my knowledge, the financial statementsand other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; 

 

4.  The Registrant’s other certifying officer(s) and I areresponsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have: 

 

a)  Designed such disclosure controls and procedures, or caused such disclosure controls andprocedures to be designed under our supervision, to ensure that material information relating to the Registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in whichthis report is being prepared; 

 

b)  Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of theperiod covered by this report based on such evaluation; 

 

c)  Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourthfiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and 

 

5.  The registrant’s other certifying officer(s) and I havedisclosed, based on our most recent evaluation of internal control over financial reporting, to the Registrant’s auditors and the audit committee of Registrant’s board of directors (or persons performing equivalent functions) : 

 

a)  all significant deficiencies and materialweaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and 

 

b)  any fraud, whether or not material, thatinvolves management or other employees who have a significant role in the registrant’s internal control over financial reporting. 

 

Date: April 22, 2005
Exhibit 32
 Certifications Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
  1.
    
    The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities
Exchange Act of 1934; and
 2.
    
    The information contained in the Report fairly presents, in all material respects, the
financial condition and results of operations of Carey Watermark Investors Incorporated.
  /s/ Michael G. Medzigian

Michael G. MedzigianChief Executive OfficerDate 05/12/11/s/ Mark J. DeCesarisMark
J. DeCesarisChief Financial Officer
* Pursuant to 5TH CIR. R. 47.5, the court has determined that

this opinion should not be published and is not precedent except

under the limited circumstances set forth in 5TH CIR. R. 47.5.4.

United States Court of Appeals

Fifth Circuit

FILED

December 12, 2005

Charles R. Fulbruge III

Clerk

IN THE UNITED STATES COURT OF APPEALS

FOR THE FIFTH CIRCUIT

 

No. 04-40636

Summary Calendar

 

UNITED STATES OF AMERICA,

Plaintiff-Appellee,

versus

RIGOBERTO JAIMES,

Defendant-Appellant.

--------------------

Appeal from the United States District Court

for the Southern District of Texas

USDC No. 5:04-CR-56-ALL

--------------------

Before HIGGINBOTHAM, BENAVIDES, and DENNIS, Circuit Judges.

PER CURIAM:*

Rigoberto Jaimes appeals his conviction and sentence for

possession with intent to distribute more than five kilograms of

cocaine. See 21 U.S.C. § 841. He argues that in light of the

Supreme Court’s recent decision in United States v. Booker, 125

S. Ct. 738 (2005), the district court erred in sentencing him under

the then-mandatory Sentencing Guidelines. Jaimes has not shown,

and the record does not support the contention, that had the

guidelines been advisory, the court would have imposed a lesser
No. 04-40636

-2-

sentence. See e.g., United States v. Valenzuela-Quevedo, 407 F.3d

728, 733 (5th Cir. 2005), petition for cert. filed (July 25,

2005)(No. 05-5556); United States v. Martinez-Lugo, 411 F.3d 597,

601 (5th Cir. 2005). Thus, he has failed to show plain error in

his sentence. See United States v. Mares, 402 F.3d 511, 520 (5th

Cir. 2005), petition for cert. filed (Mar. 31, 2005) (No. 04-9517).

AFFIRMED.
Exhibit 31.2  Section 302 Certification of Chief Financial Officer   I, Reid Stone, certify that:  1. I have reviewed this quarterly report on Form 10-Q of Laufer Bridge Enterprises, Inc.  2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report;  3. Based on my knowledge, the financial statements, and other financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this quarterly report;  4. I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-14 and 15d-14) for the registrant and have:  a) designed such disclosure controls and procedures to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to me by others within those entities, particularly during the period in which this quarterly report is being prepared;  b) evaluated the effectiveness of the registrants disclosure controls and procedures as of a date within 90 days prior to the filing date of this quarterly report (the Evaluation Date); and  c) presented in this quarterly report my conclusions about the effectiveness of the disclosure controls and procedures based on my evaluation as of the Evaluation Date;  5. I have disclosed, based on my most recent evaluation, to the registrants auditors and the audit committee of registrants board of directors (or persons performing the equivalent functions):  a) all significant deficiencies in the design or operation of internal controls which could adversely affect the registrants ability to record, process, summarize and report financial data and have identified for the registrants auditors any material weaknesses in internal controls; and  b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrants internal controls  6. I have indicated in this quarterly report whether or not there were significant changes in internal controls or in other factors that could significantly affect internal controls subsequent to the date of my most recent evaluation, including any corrective actions with regard to significant deficiencies and material weaknesses.  Date: August 18 2009  /s/ Reid Stone Reid Stone Title: Chief Financial Officer
EXHIBIT 32.1

                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

I, E. G. Marchi, President of Bio-Clean, Inc. (the "Company"), hereby certify
pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:

     (i)  the Quarterly Report on Form 10-Q of the Company, for the quarter
          ended March 31, 2010, and to which this certification is attached as
          Exhibit 32.1 (the "Report") fully complies with the requirements of
          Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as
          amended; and

     (ii) the information contained in the Report fairly presents, in all
          material respects, the financial condition and results of operations
          of the Company.


                                     By: /s/ E. G. Marchi
                                        ---------------------------------------
                                     Name:  E. G. Marchi
                                     Title: President
                                            (Principal Executive Officer)

                                     Date:  May 24, 2010

A signed original of this written statement required by Section 906 of the
Sarbanes-Oxley Act of 2002 has been provided to the Registrant and will be
retained by the Registrant and furnished to the Securities and Exchange
Commission or its staff upon request.
[Federal Register Volume 73, Number 16 (Thursday, January 24, 2008)]
[Rules and Regulations]
[Pages 4069-4070]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 08-203]


-----------------------------------------------------------------------

DEPARTMENT OF TRANSPORTATION

Federal Aviation Administration

14 CFR Part 71

[Docket No. FAA-2005-22492; Airspace Docket No. 05-AEA-020]


Amendment of Class E Airspace; St. Marys, PA

AGENCY: Federal Aviation Administration (FAA), DOT.

ACTION: Direct final rule; confirmation of effective date.

-----------------------------------------------------------------------

SUMMARY: This action confirms the effective date of a direct final rule 
that amends a Class E airspace area to support Area Navigation (RNAV) 
Global Positioning System (GPS) Special Instrument Approach Procedures 
(IAPs) that serve the Elk Regional Medical Center (7PS9), St. Marys, 
PA.

DATES: Effective 0901 UTC, December 20, 2007. The Director of the 
Federal Register approves this incorporation by

[[Page 4070]]

reference action under Title 1, Code of Federal Regulations, part 51, 
subject to the annual revision of FAA Order 7400.9 and publication of 
conforming amendments.

FOR FURTHER INFORMATION CONTACT: Daryl Daniels, Airspace Specialist, 
System Support, AJO2-E2B.12, FAA Eastern Service Center, 1701 Columbia 
Ave., College Park, GA 30337; telephone (404) 305-5581; fax (404) 305-
5572.

SUPPLEMENTARY INFORMATION:

Confirmation of Effective Date

    The FAA published this direct final rule with a request for 
comments in the Federal Register on October 30, 2007 (72 FR 61296-
61297). The FAA uses the direct final rulemaking procedure for a non 
controversial rule where the FAA believes that there will be no adverse 
public comment. This direct final rule advised the public that no 
adverse comments were anticipated, and that unless a written adverse 
comment, or a written notice of intent to submit such an adverse 
comment, were received within the comment period, the regulation would 
become effective on December 20, 2007. No adverse comments were 
received, and thus this notice confirms that effective date.

    Issued in College Park, GA on December 17, 2007.
Mark D. Ward,
Manager, System Support Group, Eastern Service Center.
[FR Doc. 08-203 Filed 1-23-08; 8:45 am]
BILLING CODE 4910-13-M
[Federal Register Volume 72, Number 30 (Wednesday, February 14, 2007)]
[Notices]
[Page 7051]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 07-646]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Human Genome Research Institute; Notice of Closed 
Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Human Genome Research Institute 
Initial Review Group, Genome Research Review Committee.
    Date: March 8, 2007.
    Time: 8:30 a.m. to 1 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 5635 Fishers Lane, 
Bethesda, MD 20892, (Telephone Conference Call).
    Contact Person: Keith McKenney, PhD, Scientific Review 
Administrator, NHGRI, 5635 Fishers Lane, Suite 4076, MSC 9306, 
Bethesda, MD 20814, 301-594-4280, <a href="/cdn-cgi/l/email-protection#cfa2aca4aaa1a1aab6a48fa2aea6a3e1a1a6a7e1a8a0b9"><span class="__cf_email__" data-cfemail="f598969e909b9b908c9eb598949c99db9b9c9ddb929a83">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.172, Human 
Genome Research, National Institutes of Health, HHS)

    Dated: February 7, 2007.
Anna Snouffer,
Acting Director, Office of Federal Advisory Committee Policy.
[FR Doc. 07-646 Filed 2-13-07; 8:45 am]
BILLING CODE 4140-07-M


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
301 S.E.2d 580

#### STATE ex rel. Timothy L. BESS v. Hon. John HEY, Judge, etc., et al.

No. 15762.

Supreme Court of Appeals of West Virginia.

March 25, 1983.

W. Ronald Denson, Charleston, for relator.

James E. Roark, Pros. Atty., Frances W. McCoy, Asst. Pros. Atty., Charleston, for respondents.

PER CURIAM:

Petitioner Timothy L. Bess, through his petition for a writ of prohibition, seeks to prohibit the State from prosecuting him on charges of unlawful possession and delivery of phenmetrazine and hydromorphone, both Schedule II controlled substances. *W.Va.Code,*60A-4-401 (1971). Bess contends that the twenty-month delay between his arrest and indictment requires that the charges against him be dismissed. We disagree and deny the writ.

The record reflects the fact that a twenty-month delay has occurred between the time of Bess’ arrest and the time of indictment. Bess cites *State ex rel. Leonard v. Hey,*W.Va., 269 S.E.2d 394 (1980) as controlling. In Syllabus point 2 of *Leonard*we held:

> “The effects of less gross delays upon a defendant’s due process rights must be determined by a trial court by weighing the reasons for delay against *the impact of the delay upon the defendant’s ability to defend himself.”*(emphasis added)

*625We recently elaborated upon this issue in Syllabus point 1 of *State v. Richey,*171 W.Va. 342, 298 S.E.2d 879 (1982).

> “The general rule is that where there is a delay between the commission of the crime and the return of the indictment or the arrest of the defendant, the burden rests initially upon the defendant to demonstrate how such delay has prejudiced his case if such delay is not *prima facie*excessive.” Syllabus point 1, *State v. Richey,*171 W.Va. 342, 298 S.E.2d 879 (1982).

An examination of the record reveals that Bess did not sustain this burden. Although Bess moved to dismiss due to the twenty-month delay, he presented no evidence at the hearing held on his motion. The state noted, as one reason for the hiatus, the delay in the receipt of the chemical analysis of the substances in Bess’ possession. The substances were submitted to the department of public safety laboratory for analysis in September of 1980 and the laboratory’s report identifying the substances was received by the prosecutor’s office in May of 1982, the same month Bess was indicted. There was absolutely no evidence presented to indicate that Bess suffered the slightest impairment in his ability to defend himself as a result of the delay. In the absence of any showing of prejudice, we find that the trial judge was correct in refusing to dismiss the charges against Bess.

Writ Denied.
May 4, 1999

Securities and Exchange Commission
450 Fifth Street, N.W.
Judiciary Plaza
Washington, D.C. 20549

Attention:  Division of Investment Management
	       
       Re:  Merrill Lynch Dragon Fund, Inc.
	    Post-Effective Amendment No. 8 to the 
	    Registration Statement on Form N-1A
	    (Securities Act File No. 33-46216
	    Investment Company Act File No. 811-6581)
	   
Ladies and Gentlemen:

   Pursuant to Rule 497 (j) under the Securities Act of 
1933, as amended (the "1933 Act"), Merrill Lynch Dragon
Fund, Inc. (the "Fund")hereby certifies that:

   (1) the form of prospectus and statement of additional 
       information that would have been filed pursuant to 
       Rule 497 (c) under the 1933 Act would not have 
       differed from that contained in Post-Effective 
       Amendment No. 10 to the Fund's Registration Statement
       on Form N-1A, constituting the most recent amendment 
       to the Fund's Registration Statement on Form N-1A; 
       and
	
   (2) the text of Post-Effective Amendment No. 10 to the 
       Fund's Registration Statement on Form N-1A was filed 
       electronically with the Securities and Exchange 
       Commission on April 26, 1999.

				 Very truly yours,
					
		     	  Merrill Lynch Dragon Fund, Inc.

			By:    /s/ Phillip S. Gillespie
			     _________________________
				 Phillip S. Gillespie                
			   	      Secretary